Taking Mounjaro and Testosterone Together: What the Evidence Shows

What clinical guidance and the SmPC actually say about this combination

The BNF monograph for tirzepatide and Mounjaro's Summary of Product Characteristics both list potential interactions based on gastric-emptying delay. Because Mounjaro slows the movement of food through the stomach, oral medicines taken at the same time may be absorbed more slowly or at a lower peak concentration. Testosterone, however, is rarely taken as an oral capsule in UK clinical practice; the standard routes (subcutaneous or intramuscular injection, transdermal gel, or patch) bypass gastric absorption entirely. For most men on testosterone replacement therapy, that particular interaction pathway simply does not apply.

The NHS medicines page for tirzepatide lists no testosterone-specific interaction. Neither does the prescribing information classify androgens among the medicines requiring timing adjustments. That said, an absence of a flagged interaction is not the same as a green light without clinical review. Your prescriber should know about every medicine and hormone therapy you take before writing a Mounjaro prescription, that is standard practice, not a precaution unique to this combination.

If you take oral testosterone undecanoate (a less common but available formulation in the UK), the gastric-emptying effect is worth raising explicitly with whoever manages your hormone therapy, so they can monitor levels and adjust if needed. It is also worth knowing that Mounjaro does not currently come in a pill form, so any discussion about oral absorption concerns relates solely to the other medicines in your regimen, not to tirzepatide itself.

What weight loss does to testosterone levels in men with obesity

This is where the biology gets genuinely interesting. Obesity suppresses endogenous testosterone production. Excess adipose tissue converts androgens to oestrogens via aromatase, and high circulating insulin reduces luteinising hormone pulsatility, both effects lower free testosterone. Men with a higher BMI are significantly more likely to present with low testosterone than men at a healthy weight, and this is often not primary hypogonadism but a metabolic consequence of weight itself.

In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants using tirzepatide at the highest doses achieved an average body-weight reduction of around 20–21% over 72 weeks. Reductions of that scale consistently improve the hormonal environment in men: studies of bariatric surgery and significant diet-induced weight loss have shown meaningful rises in free and total testosterone as weight falls, in some cases bringing levels back into the normal range without any change to exogenous therapy.

What this means practically: if you are on testosterone replacement and you lose a substantial amount of weight on Mounjaro, your baseline testosterone (the value that originally justified the prescription) may no longer reflect your current physiology. Your hormone specialist may want to recheck levels at intervals. That is a conversation worth having before you start, not after six months of treatment. You can read more about how Mounjaro affects testosterone levels in more detail.

Practical considerations before combining both treatments

Starting tirzepatide when you are already established on testosterone replacement therapy is, in most cases, clinically manageable. A few practical points are worth knowing. First, if your testosterone is delivered by injection, there is no timing interaction with Mounjaro's once-weekly injection, they can be given on different days or the same day, in different sites, without one affecting the other's pharmacokinetics. Second, nausea is common in the early weeks of Mounjaro; if it is severe enough to reduce food intake significantly, it is worth telling both your Mounjaro prescriber and whoever manages your testosterone, so nothing is attributed to the wrong cause.

Third, body composition changes during treatment. Mounjaro reduces fat mass; testosterone, particularly in men with low levels, supports lean muscle mass. Used together under appropriate supervision, there is a reasonable argument that the combination supports favourable body composition changes, but that is a clinical assessment, not a self-managed experiment. Dose titration of either treatment should follow professional guidance, not a personal schedule.

If you are considering Mounjaro for the first time and want to understand how it might fit around your current care, our overview of Mounjaro and testosterone sets out the key clinical considerations. A common question at this stage is whether Mounjaro and tirzepatide can be taken together, and that page explains the relationship between the two in plain terms. For context on how tirzepatide relates to testosterone levels in men specifically, that page covers the evidence in depth.

Women prescribed testosterone (used off-label for libido or fatigue in some cases in the UK) should discuss their full treatment list with a prescriber; the hormonal context differs but the principle is the same. Separately, if you are on HRT, our page on taking Mounjaro and HRT together covers the specific guidance around oestrogen and progestogen formulations, including the MHRA's advice on oral contraceptive pill absorption during tirzepatide treatment.

Mounjaro is one option among several for medically supervised weight loss. If you want a broader picture of what weight-loss treatment looks like as a whole, that is a useful starting point before a consultation.